603983.SS
603983.SS
CNE100003M51
GUANGDONG MARUBI BIOTECHNOLOGY
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 3.459.318.084 2.969.770.567
16.5%
Cost of Revenue 889.519.268 781.028.905
13.9%
Gross Profit 2.569.798.816 2.188.741.661
17.4%
2.315.890.401 1.828.856.143
26.6%
Operating Income 253.908.414 359.885.518
29.4%
Pretax Income 295.731.445 380.656.509
22.3%
Net Income Common Stockholders 247.239.141 341.628.708
27.6%
-- --
--
-- --
--
ende